Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
Open Access
- 31 January 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0263014
Abstract
The correlation between immune responses and protection from SARS-CoV-2 infections and its duration remains unclear. We performed a sanitary surveillance at the European Institute of Oncology (IEO) in Milan over a 17 months period. Pre-vaccination, in 1,493 participants, we scored 266 infections (17.8%) and 8 possible reinfections (3%). Post-vaccination, we identified 30 infections in 2,029 vaccinated individuals (1.5%). We report that the probability of infection post-vaccination is i) significantly lower compared to natural infection, ii) associated with a significantly shorter median duration of infection than that of first infection and reinfection, iii) anticorrelated with circulating antibody levels.Keywords
All Related Versions
Funding Information
- Fondazione Europea Guido Venosta
- National Instruments Corporation
This publication has 27 references indexed in Scilit:
- Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional studyClinical Microbiology and Infection, 2021
- Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care WorkersJournal of Clinical Medicine, 2020
- Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2New England Journal of Medicine, 2020
- Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patientsJournal of Infection, 2020
- Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?Clinical Infectious Diseases, 2020
- Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyeLife, 2020
- The immunology of SARS-CoV-2 infections and vaccinesSeminars in Immunology, 2020
- Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Duration of RT-PCR positivity in severe acute respiratory syndromeEuropean Respiratory Journal, 2005